Artery ablation for type 2 diabetes with kidney and liver arteries
Part of Heart & circulation, Hormones & metabolism clinical trials.
This Phase 1 study tests whether a minimally invasive artery procedure can improve type 2 diabetes and related health problems by targeting kidney and liver blood vessels. Because it’s early-stage, the main goal is safety and learning how the treatment works in people who meet specific diabetes, blood pressure, and blood test requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 21 to 65 years old
- Have type 2 diabetes for 10 years or less and be taking metformin (with possible add-on oral pills)
- Have diabetes lab levels in a specific range (HbA1c 7.0%–9.0% and fasting glucose 140–270 mg/dL) and triglycerides under 400 mg/dL
- Have high blood pressure that fits study numbers and stays on up to three blood-pressure medicines (not beta blockers or alpha blockers)
- Have a BMI between 27.5 and 40, and enough “C-peptide” on a blood test (at least 2 ng/mL)
- Have suitable kidney and liver artery size and access for the procedure (no major blockages or unsafe anatomy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a new artery “ablation” procedure for people with type 2 diabetes, aiming to improve diabetes and related conditions like high blood pressure. It will also check whether the procedure is safe and works well enough to study further.
This study tests a new device that uses energy to calm kidney nerves, which may help lower blood pressure in people with chronic kidney disease whose blood pressure stays high despite taking multiple medications.
This trial tests a procedure called renal denervation to lower blood pressure in people whose medication isn't enough. It uses a special catheter to calm nerves near the kidneys that may be overactive.
This trial tests a procedure called renal denervation for people with untreated high diastolic blood pressure. The procedure uses a small catheter to interrupt nerve signals around the kidneys, which may help lower blood pressure.
This trial tests whether a procedure that uses heat energy (radiofrequency vapor ablation) applied in the first part of the small intestine (duodenum) can improve blood sugar control in adults with type 2 diabetes. It may help lower blood sugar when standard oral medicines are not keeping it in range.
This trial tests a procedure that targets nerves near the kidney (renal denervation) to help lower blood pressure in people whose hypertension is not controlled despite medication. It uses a special 3D mapping system to guide the procedure.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.